SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-24-000017
Filing Date
2024-02-23
Accepted
2024-02-22 17:55:27
Documents
21
Period of Report
2024-02-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20240220.htm   iXBRL 8-K 39600
2 EX-10.1 exhibit1012.htm EX-10.1 56493
3 EX-10.2 exhibit1022.htm EX-10.2 168530
4 EX-10.3 exhibit103.htm EX-10.3 7344
5 EX-10.4 exhibit104.htm EX-10.4 80692
6 EX-10.5 exhibit105.htm EX-10.5 17799
7 EX-99.1 a022224slrxrestructuringfi.htm EX-99.1 20527
11 image_0a.jpg GRAPHIC 77186
  Complete submission text file 0001615219-24-000017.txt   702236

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240220.xsd EX-101.SCH 1926
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240220_lab.xml EX-101.LAB 23894
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240220_pre.xml EX-101.PRE 12543
22 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240220_htm.xml XML 2724
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 24666454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)